Subscribe To
STAB / Statera Biopharma (STAB) Stock: Why The Price Substantially Fell Today
STAB News
By Benzinga
February 7, 2022
Statera Biopharma Shares Tumble After Raising $2M Via Equity
Statera Biopharma Inc STAB has announced a registered direct offering of $2 million common stock and warrants. Get the Inside Access Traders Are Us more_horizontal
By Benzinga
February 7, 2022
Statera Biopharma Shares Tumble After Raising $2M Via Equity
Statera Biopharma Inc STAB has announced a registered direct offering of $2 million common stock and warrants. Get the Inside Access Traders Are Us more_horizontal
By Benzinga
February 7, 2022
Statera Biopharma Shares Tumble After Raising $2M Via Equity
Statera Biopharma Inc STAB has announced a registered direct offering of $2 million common stock and warrants. Get the Inside Access Traders Are Us more_horizontal
By Pulse2
February 7, 2022
Statera Biopharma (STAB) Stock: Why The Price Substantially Fell Today
The stock price of Statera Biopharma, Inc. (NASDAQ: STAB) fell by over 15% pre-market today. This is why it happened. more_horizontal
By Pulse2
February 7, 2022
Statera Biopharma (STAB) Stock: Why The Price Substantially Fell Today
The stock price of Statera Biopharma, Inc. (NASDAQ: STAB) fell by over 15% pre-market today. This is why it happened. more_horizontal
By Pulse2
February 7, 2022
Statera Biopharma (STAB) Stock: Why The Price Substantially Fell Today
The stock price of Statera Biopharma, Inc. (NASDAQ: STAB) fell by over 15% pre-market today. This is why it happened. more_horizontal
By GlobeNewsWire
October 6, 2021
Statera Biopharma, Inc. to Participate in the A.G.P. Biotech and Specialty Pharma Conference
FORT COLLINS, Colo., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-gener more_horizontal
By GlobeNewsWire
October 6, 2021
Statera Biopharma, Inc. to Participate in the A.G.P. Biotech and Specialty Pharma Conference
FORT COLLINS, Colo., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-gener more_horizontal